Johnson & Johnson
5 things to know before the stock market opens Monday
Netflix signage next to the Nasdaq MarketSite in New York, U.S., on Friday, Jan. 21, 2022. Michael Nagle | Bloomberg | Getty Images Here are the most important news items that investors need to start their trading day: 1. Big earnings week More quarterly earnings reports will stream in this week as companies and investors […]
Read More
FDA authorizes Novavax Covid vaccine for adults as the first new shots in U.S. in more than a year
In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration has authorized Novavax’s two-dose vaccine for adults ages 18 and over, the fourth Covid shot to get emergency approval in the U.S. […]
Read More
We’re adding shares of a health-related company with a resilient revenue stream in rough times
With this stock around our overall cost basis, we want to take the opportunity to get some cash to work and increase our exposure. Source
Read More
Jim Cramer picks 4 ‘buyable’ stocks to snap up after ugly market days
CNBC’s Jim Cramer recommended four stocks investors should consider adding to portfolios after ugly days in the market like Tuesday. “While this may be a bear market, as long as commodity prices keep coming down, these stocks should be winners, which is why you’ve got to treat ugly moments like this one as buying opportunities,” […]
Read More
FDA panel recommends changing Covid shots to fight omicron this fall
A healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, January 29, 2021. Mike Segar | Reuters The Food and Drug Administration’s panel of independent vaccine experts on Tuesday voted 19 to 2 to […]
Read More
We’re trimming a winner we still believe in to raise some cash and right-size our position
We do not want to be greedy like we were with our oil names. We do not want to make the same mistake twice. Source
Read More
Tuesday’s market bounce allows us to raise some cash to buy in the next downturn
We’re raising cash about equal to what we put to work last Friday in three trades when the market was much lower. Source
Read More
We’re buying small in the market carnage, picking our lanes to put cash to work
The Club still thinks a broad-based selloff like Monday is creating a long-term opportunity in stocks with little to do with the concerns of the moment. Source
Read More
FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images The Food and Drug Administration needs to review changes to Novavax’s manufacturing process before it can authorize the biotech […]
Read More
Cramer’s lightning round: Enbridge is a buy
Blackline Inc: “They’re losing money. … We can just not go with it.” MetLife Inc: “I’m going to have to say yes to that, even as I’m not a great fan of the insurers. … That is too cheap a stock.” Farfetch Ltd: “I say, buy Target down here.” Disclosure: Cramer’s Charitable Trust owns shares […]
Read More